The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InBaxter International Inc. (NYSE:BAX) reported a significant earnings miss for the fourth quarter of 2025, alongside a notably weak outlook for 2026, leading to a sharp decline in its stock price. The company announced an adjusted EPS of $0.44 for Q4 2025, falling considerably short of analyst estimates. Furthermore, Baxter provided cautious guidance for 2026, projecting reported sales growth between 0% and 1% and adjusted EPS in the range of $1.85 to $2.05. This weak forecast, coupled with a substantial GAAP loss driven by goodwill impairment, has raised significant concerns among investors regarding the company's profitability and operational turnaround. Consequently, shares of Baxter plummeted following the disappointing financial disclosures, reflecting a severe blow to investor confidence.